Skip Navigation LinksHome > August 2012 - Volume 34 - Issue 6 > Methemoglobin Reductase Deficiency: Novel Mutation Is Assoc...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e318257a492
Clinical and Laboratory Observations

Methemoglobin Reductase Deficiency: Novel Mutation Is Associated With a Disease Phenotype of Intermediate Severity

Percy, Melanie J. PhD, FRCPath; Barnes, Chris MBBS, FRACP, FRCPA; Crighton, Gemma MD; Leventer, Richard J. MBBS, BMedSci, PhD, FRACP; Wynn, Robert MA, MD, MRCP, FRCPath; Lappin, Terence R. PhD, FRCPath

Collapse Box


Background: Cytochrome b5 reductase (CB5R) deficiency is a recessively inherited autosomal disorder that is either benign (type I) or associated with severe neurological problems (type II). Specific mutations in the CYB5R gene are not exclusive to each type.

Observation: Two cyanotic children with developmental delay but with slow progression were investigated for CB5R deficiency. A novel mutation, p.Arg58Pro, was independently detected in both cases.

Conclusions: The clinical variability and severity of the disease reflect the combined effects of impaired function of the 2 mutant enzymes. As illustrated by these 2 cases, inheritance of p.Arg58Pro with either p.Gly76Ser or pLeu188del causes a clinical condition more severe than type I and less severe than the type II cases reported to date.

Copyright © 2012 Wolters Kluwer Health, Inc. All rights reserved.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.